Neal Benowitz
Neal Benowitz is a renowned pharmacologist and toxicologist known for his extensive research in the field of nicotine addiction. He is currently a Professor Emeritus of Medicine and Bioengineering & Therapeutic Sciences at the University of California, San Francisco (UCSF).
Early Life and Education[edit | edit source]
Neal Benowitz was born and raised in New York City. He completed his undergraduate studies at Columbia University, where he developed an interest in pharmacology. He then pursued his medical degree from the University of Rochester School of Medicine and Dentistry.
Career[edit | edit source]
After completing his medical degree, Benowitz moved to San Francisco, where he joined the University of California, San Francisco (UCSF) as a resident in internal medicine. He later became a fellow in clinical pharmacology and toxicology at UCSF, where he began his research on nicotine addiction.
Benowitz's research primarily focuses on the human pharmacology of nicotine in relation to addiction, smoking cessation, and the health effects of tobacco use. His work has significantly contributed to the understanding of nicotine addiction and has influenced public health policy and regulation of tobacco products.
Contributions to Pharmacology[edit | edit source]
Benowitz has published over 700 scientific articles and has co-authored several books on pharmacology and toxicology. His research has been instrumental in the development of nicotine replacement therapies and in the formulation of public health policies regarding tobacco control.
He has served on numerous scientific and advisory committees, including the Food and Drug Administration's (FDA) Tobacco Products Scientific Advisory Committee and the World Health Organization's Study Group on Tobacco Product Regulation.
Awards and Recognition[edit | edit source]
Benowitz's contributions to the field of pharmacology have earned him numerous awards and recognition. He is a fellow of the American Society for Clinical Pharmacology and Therapeutics and a member of the American Association for the Advancement of Science.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
